Location History:
- Sete, FR (2017)
- Sète, FR (2015 - 2022)
Company Filing History:
6 out of 5,081 
6 out of 290 
5 out of 1,743 
Years Active: 2015-2022
Title: Julie Pannequin: Innovator in Monoclonal Antibodies
Introduction
Julie Pannequin is a prominent inventor based in Sète, France. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 7 patents to her name, her work has the potential to impact cancer treatment and diagnostics.
Latest Patents
Among her latest patents is a groundbreaking innovation involving monoclonal antibodies to progastrin. This patent outlines methods for creating and utilizing these antibodies, which are crucial for treating colorectal cancer. The disclosure includes techniques for detecting progastrin, which can aid in diagnosing colorectal cancer and monitoring the effectiveness of anti-cancer therapies.
Career Highlights
Julie has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Les Laboratoires Servier. Her experience in these institutions has allowed her to refine her expertise in antibody research and development.
Collaborations
Throughout her career, Julie has collaborated with notable individuals, including Dominique Joubert and Frédéric Hollande. These partnerships have contributed to her innovative research and advancements in the field.
Conclusion
Julie Pannequin's work in monoclonal antibodies represents a significant advancement in cancer treatment and diagnostics. Her contributions continue to shape the future of biotechnology and improve patient outcomes.